Carol I. Geppert

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair et al. · European Journal of Cancer · 2018 · 100 citations

Urology, Genitourinary Cancer, Therapy Stratification +10

Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study

Frederik A. Stuebs, Carla E. Schulmeyer, Grit Mehlhorn et al. · Archives of Gynecology and Obstetrics · 2018 · 73 citations

Retrospective Study, Cervical Cancer Screening, Cervical Cancer +12

NFATc1 Promotes Antitumoral Effector Functions and Memory CD8+ T-cell Differentiation during Non–Small Cell Lung Cancer Development

Lisanne Heim, Juliane Friedrich, Marina Engelhardt et al. · Cancer Research · 2018 · 63 citations

Inflammatory Lung Disease, Immunology, Immunoediting +16

Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy

Markus Eckstein, Pamela L. Strissel, Reiner Strick et al. · Journal for ImmunoTherapy of Cancer · 2020 · 58 citations · Full text

High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma

Iris Polifka, Abbas Agaimy, Edwin Herrmann et al. · Human Pathology · 2018 · 45 citations · Full text